欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3157/001
药品名称Spiolto Respimat
活性成分
    • olodaterol 2.5 mg/dose
    • tiotropium bromide 2.5 mg/dose
剂型Inhalation solution
上市许可持有人Boerhinger Ingelheim International GmBH/DE
参考成员国 - 产品名称Netherlands (NL)
Spiolto Respimat 2,5 microgram/2,5 microgram, inhalatieoplossing
互认成员国 - 产品名称
    • Germany (DE)
      Spiolto Respimat 2,5 Mikrogramm /2,5 Mikrogramm pro Hub Lösung zur Inhalation
    • Denmark (DK)
      Spiolto Respimat
    • Belgium (BE)
      Spiolto Respimat 2,5 microgrammes/2,5 microgrammes/inhalation, solution à inhaler
    • Luxembourg (LU)
      Spioloto Respimat Solution pour inhalation en flacon pressurisé
    • Iceland (IS)
      Spiolto Respimat 2,5/2,5 míkróg Innöndunarlausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Liechtenstein (LI)
    • Austria (AT)
      Spiolto Respimat 2,5 Mikrogramm/2,5 Mikrogramm Inhalationslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      SPIOLTO® RESPIMAT
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Latvia (LV)
      Spiolto Respimat 2,5 mikrogrami/2,5 mikrogrami šķīdums inhalācijām
    • Lithuania (LT)
      Spiolto Respimat 2,5 mikrogramo/2,5 mikrogramo/išpurškime įkvepiamasis tirpalas
    • Estonia (EE)
      SPIOLTO RESPIMAT
    • Hungary (HU)
      SPIOLTO RESPIMAT 2,5 mikrogramm/2,5 mikrogramm, inhalációs oldat
    • Bulgaria (BG)
      Spiolto Respimat
    • Cyprus (CY)
      SPIOLTO RESPIMAT INHALATION SOL
    • Czechia (CZ)
      Spiolto Respimat 2,5 mikrogramů/ 2,5 mikrogramů
    • Romania (RO)
      Spiolto Respimat 2,5 micrograme/2,5 micrograme soluţie de inhalat
    • Slovakia (SK)
      Spiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhalačný roztok
    • Slovenia (SI)
    • Malta (MT)
      Spiolto Respimat
    • Croatia (HR)
      Spiolto Respimat 2,5 mikrograma/2,5 mikrograma, otopina inhalata
    • Finland (FI)
许可日期2015/05/20
最近更新日期2024/02/09
药物ATC编码
    • R03A ADRENERGICS, INHALANTS
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase